| Breast cancer stem cells: A review of their characteristics and the agents that affect them NL Shan, Y Shin, G Yang, P Furmanski, N Suh Molecular carcinogenesis 60 (2), 73-100, 2021 | 51 | 2021 |
| Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy SK Nikkhoi, G Li, S Eleya, G Yang, VG Vandavasi, A Hatefi Frontiers in immunology 13, 1039969, 2023 | 28 | 2023 |
| Inhibitors of Keap1-Nrf2 protein-protein interaction reduce estrogen responsive gene expression and oxidative stress in estrogen receptor-positive breast cancer T Xie, H Zahid, AR Ali, R Joyce, G Yang, C Winz, Y Le, R Zhou, ... Toxicology and applied pharmacology 460, 116375, 2023 | 7 | 2023 |
| A high affinity and specificity anti-Her2 single-domain antibody (VHH) that targets Trastuzumab’s EPITOPE with versatile biochemical, biological, and medical applications SK Nikkhoi, H Heydarzadeh, VG Vandavasi, G Yang, P Louro, M Polunas, ... Immunologic Research 72 (1), 103-118, 2024 | 4 | 2024 |
| Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice SK Nikkhoi, G Yang, H Owji, M Grizotte-Lake, RI Cohen, LG Gonzalez, ... Journal for ImmunoTherapy of Cancer 12 (3), 2024 | 3 | 2024 |
| A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide G Yang, SK Nikkhoi, H Owji, G Li, M Massumi, J Cervelli, VG Vandavasi, ... Antibodies 13 (3), 75, 2024 | | 2024 |
